prostate cancer cells
Identification of a C-FABP-PPARγ-VEGF axis promoting tumorigenicity in prostate cancer cells
232
Upregulation of death receptor 5 and activation of caspase 8/3 play a critical role in ergosterol peroxide induced apoptosis in DU 145 prostate cancer cells
8
Dihydroisotanshinone I combined with radiation inhibits the migration ability of prostate cancer cells through DNA damage and CCL2 pathway
10
Original Article Silencing of CCR7 inhibits the growth, invasion and migration of prostate cancer cells induced by VEGFC
8
Original Article miR-24-3p stimulates migration, invasion and proliferation of prostate cancer cells by targeting suppressor of cytokine signaling 6
8
MCM3AP-AS1/miR-876-5p/WNT5A axis regulates the proliferation of prostate cancer cells
12
EVALUATION OF ANTICANCER PROPERTY OF GOSSYPOL USING HeLa CELL LINE
10
Gene Expression Profile, Androgen Independence and Prostate Cancer
8
Dickkopf 1 is regulated by the mevalonate pathway in breast cancer
13
Original Article LKB1 suppresses proliferation and invasion of prostate cancer through hedgehog signaling pathway
9
Original Article NUAK1 knockdown suppresses prostate cancer cell epithelial-mesenchymal transition, migration, and invasion through microRNA-30b-5p
11
The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer
16
Androgen deprivation–induced NCoA2 promotes metastatic and castration resistant prostate cancer
15
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function
14
Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
13
Potential use of STAT3 inhibitors in targeted prostate cancer therapy: future prospects
7
MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer
17
USP35 activated by miR let-7a inhibits cell proliferation and NF-κB activation through stabilization of ABIN-2
16
SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression
13
The role of QRFP & GPR103 in human prostate cancer
282